Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Recombinant human elafin

EU orphan designation number: EU/3/09/710   
Active ingredient: Recombinant human elafin
Indication: Treatment of oesophagus carcinoma
Sponsor: Proteo Biotech AG
Am Kiel Kanal 44, 24106 Kiel, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Orphan designation EMEA/OD/057/09 (2010)656 of 28/01/2010